Navigation Links


SpineFrontier Enhances the MISquito Percutaneous Pedicle Screw System in Response to Growing Demand

1/20/2017
MALDEN, MA (PRWEB) January 20, 2017 SpineFrontier, Inc., the leader in Less Exposure Surgery (LES®) Technologies, announced today the next evolution in spinal fusion, the MISquito Percutaneous Pedicle Screw System (part of the PedFuse Pedicle Screw System platform). In contrast to the co... [Comments]

Cancer Biomarkers Market - Global Opportunity Analysis and Industry Forecast 2014-2022: Omics Accounted for More Than Half of the $6.5 Billion Market - Research and Markets

1/19/2017
DUBLIN , Jan 19, 2017 Research and Markets has announced the addition of the "Cancer Biomarkers Market by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their offering. Cancer Biomarkers Market Report, forecasts that the global market is projected to reach $15,737 mi... [Comments]

Liquid Biopsy Market is Predicted to Grow at a CAGR of 21.6% from 2016 to 2022

1/19/2017
PUNE, India , Jan. 19, 2017  Market Research Future has a half cooked research report on Global Liquid Biopsy Market. The Global Market for Liquid Biopsy is growing rapidly and expected to reach USD 450 Million by the end of the forecasted period. Market Highlights The Global Liquid Biopsy Market has been assessed as a swiftly growing market and expect... [Comments]

NX Prenatal Appoints Leading Experts to Medical/Clinical Advisory Board

1/19/2017
LOUISVILLE, Ky. and HOUSTON , Jan. 19, 2017 NX Prenatal Inc. ("NX Prenatal") today announced the formation of its Medical/Clinical Advisory Board.  This new board brings together leading clinicians and industry veterans who enhance the range and depth of expertise of the company as it accelerates development of its novel prenatal diagnostic tests.  These experts... [Comments]

WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences

1/19/2017
SHANGHAI , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that it has acquired HD Biosciences (HDB), a leading biology focused preclinical drug discovery contract research organization (CRO). After completion of acquisition, HD Biosciences will become a wholly-owned sub... [Comments]

Implantable Biomaterials Market Material, Application Analysis & Trends 2016-2025: $150+ Billion Growth Opportunities/Investment Opportunities - Research and Markets

1/19/2017
DUBLIN , Jan 19, 2017 Research and Markets has announced the addition of the "Implantable Biomaterials Market Analysis & Trends - Material, Application - Forecast to 2025" report to their offering. Report Highlights: The report provides a detailed analysis on current and future market trends to identify the investment opportunities... [Comments]

Genedata Launches Data Science Services for Precision Medicine

1/19/2017
Basel, Switzerland (PRWEB) January 19, 2017 Genedata, a leading provider of advanced software solutions for pharmaceutical research and development (R&D), today announced the launch of Data Science Services , offering on-demand, project-based expertise in omic data analysis and interpret... [Comments]

November Research Group Announces the Availability of PRIMO Mail

1/19/2017
Berkeley, CA (PRWEB) January 19, 2017 November Research Group, LLC, a global leader in the delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is proud to announce the worldwide release of PRIMO Mail. PRIMO Mail is a fully 21 CF... [Comments]

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

1/19/2017
ANNAPOLIS, Md. and GAITHERSBURG, Md. , Jan. 19, 2017  PharmAthene, Inc. (NYSE MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious diseases, announced today the signing of a definitive agreement for the merger of PharmAthene and Altimmune in an all-stock transaction. Altimmune's current investors include Novartis Venture Fund,... [Comments]

ArmaGen Appoints Mathias Schmidt, Ph.D., as Chief Executive Officer

1/19/2017
CALABASAS, Calif. , Jan. 19, 2017  ArmaGen, Inc., today announced that it has appointed Mathias Schmidt , Ph.D., as chief executive officer, as well as a member of ArmaGen's board of directors. Dr. Schmidt brings to ArmaGen more than 17 years of executive management experience focused on the research and development of biotherapeutics and pharmaceuticals. "Mathias... [Comments]

[next]
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
(Date:12/16/2016)... Dec 16, 2016 Research and Markets has ... - Global Forecast to 2021" report to their offering. ... The biometric vehicle ... at a CAGR of 14.06% from 2016 to 2021. The market ... projected to reach 854.8 Million by 2021. The growth of the ...
(Date:12/15/2016)... ... announced the addition of the "Global Military Biometrics Market 2016-2020" ... military biometrics market to grow at a CAGR of 7.5% during the ... an in-depth market analysis with inputs from industry experts. The report covers ... report also includes a discussion of the key vendors operating in this ...
Breaking Biology News(10 mins):
...
... APAgene kits are designed to rapidly and ... our patented APA Technology. APAgene provides hassle-free, ... price. All necessary ingredients are provided in ... can be used for insert-end amplification of ...
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Protein YIPF6 (YIP1 family member 6). [Source:Uniprot/SWISSPROT;Acc:Q96EC8] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products:
(Date:1/19/2017)... Research and Markets has announced the addition ... Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... is projected to reach $15,737 million by 2022 from $6,521 in ... Omic technologies segment accounted for more than half ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi ... device open-access capability and technology platform, today announced ... leading biology focused preclinical drug discovery contract research ... will become a wholly-owned subsidiary of WuXi, and ... competences and providing greater services. The acquisition will ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, LLC, a ... medical device manufacturers and regulators, is proud to announce the worldwide release of ... designed to provide product vigilance departments with the flexibility and ease of use ...
(Date:1/19/2017)... , Jan. 19, 2017 AquaBounty Technologies, ... on enhancing productivity in aquaculture and a majority-owned subsidiary ... that it has completed the listing of its common ... equity subscription from Intrexon. "AquaBounty,s listing on ... will broaden our exposure to the U.S. markets as ...
Breaking Biology Technology: